M. Bayer retweeted
👏 The Wait is over
🚀 The 'ERC 2025 Cardio Pulmonary Resuscitation Guidelines' is Released.
🫀 Click the link to know more
👉 erc.edu/news/2025-erc-guidel…
#ERC #CPR #Guidelines2025 #ERCGuidelines #savelives #RESUS25
M. Bayer retweeted
The @ERC_resus 2025 cardio-pulmonary resuscitation guidelines are out!
🫀 adult basic & advanced life support
🧸 pediatric life support
🍼 neonatal life support
🚧 special circumstances
🩺 ERC & @ESICM post-resuscitation care
⚖️ ethics
📋 system saving lives
🎓 education for #resuscitation
🔍 epidemiology
🩹 first aid
@ResusJournal 🔓 bit.ly/4qkPTWO
#ECPR? may be considered as rescue therapy for selected adults with IHCA & OHCA when conventional CPR is failing to restore spontaneous circulation, in settings in which this can be implemented. Consider #ECLS as early intervention for selected infants & children with IHCA ( eg cardiac conditions in #PedsICU and periop) and OHCA where resources allow. Whether initiating #ECPR for OHCA in pre vs in hospital is superior remains uncertain (ongoing trials).
In hypothermic CA, consider ECMO assisted rewarming (vs CPB); unwitnessed CA with asystole as first rhythm is NOT contraindication for ECLS rewarming. If ECLS is not available within 6 h, non-ECLS rewarming may be used. In the cath-lab, ECPR may be considered for selected patients to facilitate diagnostic or therapeutic procedures, including coronary angiography/angioplasty, pulmonary embolectomy or cardiac surgery.
In selected respiratory pts (unconscious, severe hypoxemia) VV may be an option to prevent hypoxic CA). If available, early ECMO can be considered in pregnant patients with signs of impending circulatory collapse.
🔓 bit.ly/4qoep9G
M. Bayer retweeted
Left Ventricular venting & brain injury in peripheral VA #ECMO
🔍 ELSO Registry > 13K adults on #ECLS for CS
🫀 LV venting 11%: 65.5% percutaneous microaxial flow pump, 29.9% IABP
🧠 LV venting associated w increased risk of ABI (HIBI, ischemic stroke, ICH)
🪦 similar mortality if LV vented/non: unmeasured benefit of LV venting?
🫀 no difference in ABI or mortality if IABP vs mAFP
@CritCareMed
🖇️ bit.ly/4hng6QK
M. Bayer retweeted
Acute coronary syndromes: mechanisms, challenges, and new opportunities: @ESC_Journals
🥸Very nice review -
😱Many research questions
👇👇👇
M. Bayer retweeted
Just published: cardiac arrest subanalysis of ECLS-SHOCK ahajournals.org/doi/full/10.… @JaninePoss @CHassager @cjungMD
M. Bayer retweeted
LV decompression in pediatric patients on VA #ECMO?
Several challenges in this vulnerable population: small size limits range of available techniques. Role remains controversial and variably adopted. Benefit appears more consistent in PC setting. Despite a generally favourable safety profile, each technique carries specific procedural risks/complication profiles that must be carefully weighed against potential benefits.
#FOAMcc #FOAMecmo #PedsICU
🔓 bit.ly/45wjN2H
M. Bayer retweeted
ECPR for refractory cardiac arrest
🩺 physiology/rationale
⚒️ technical considerations
🔍 (growing) evidence
‼️ special circumstances
⚖️ patient selection
⏱️ timing/setting & post-ECPR care
🎓 training
🚧 risks/complications
🥅 goals
🎁 organ donation
💵 economic impact & justice
@LancetRespirMed #FOAMcc
🖇️ bit.ly/3HjVSsV
M. Bayer retweeted
Coronary, renal & cerebral perfusion of VA #ECMO + #IABP in refractory cardiogenic shock
🔬in vitro study
🫀hemodynamic effects depend on CO, HR, site of #ECLS arterial cannulation
If severe low CO, axillary artery (vs femoral) cannulation + IABP showed greatest benefit in terms of coronary/cerebral flow but renal perfusion negatively affected.
#FOAMcc #FOAMecmo @asaiojournal
🔓 bit.ly/4jnn7jQ
M. Bayer retweeted
🆕 Neue S3-Leitlinie zur Nierenersatztherapie bei AKI in der Intensivmedizin! Erstmals evidenzbasierte Empfehlungen der @AWMF_eV mit @DGK_org : Prof. @floriancustodis & Dr. @BayerMatthias geben einen Überblick.
➡️ herzmedizin.de/fuer-aerzte-u…
#Herzmedizinde #DGK #BNK
M. Bayer retweeted
Left ventricular unloading in #ECPR
🔎 > 3.2K pts from ELSO Registry, 2020-2023
⚖️ 621 pairs (LV unloading +/-) matched
🚧 LV unloading associated with higher complications
🫀not associated with improved survival/functional outcomes in context of #ECMO assisted CPR regardless of unloading device, etiology of CA, presenting rhythm, demographic or centre characteristics
#FOAMcc @Crit_Care
🔓rdcu.be/eln4M
M. Bayer retweeted
2025 US guidelines for the management of ACS (STEMI and NSTE-ACS) just released. Insertion of a
microaxial flow pump (Impella) to prevent death in in cardiogenic shock has received a class IIa LOE B-R recommendation. IABP and VA-ECMO are class III for rourine use.
M. Bayer retweeted
🔴Anticoagulation Medications, Monitoring, and Outcomes in Patients with Cardiogenic Shock Requiring Temporary MCS⤵️ #2024Review @JCardFail
🔹onlinejcf.com/article/S1071-…
#echofirst #CardioX #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #ECG
M. Bayer retweeted
Besinnliche Weihnachten und ein gesundes neues Jahr 2025!
HERZliche Grüße, Ihr Team der Medizinischen Klinik I|
M. Bayer retweeted
Does delivering chest compressions to patients who are not in cardiac arrest cause unintentional injury? A systematic review
🔗 sciencedirect.com/science/ar…
#ResuscitationPlus
M. Bayer retweeted
#Herz
Vorträge zur Herzinsuffizienz
#UKGM #Gießen #Kardiologie #Herzchirurgie
giessener-allgemeine.de/krei…
M. Bayer retweeted
Very nice overview of the current state of affairs in cardiogenic shock (published this week in @TheLancet):
M. Bayer retweeted
ILCOR Summary Statement: 2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the BLS; ALS; PLS; NLS; EIT; and FA Task Forces
resuscitationjournal.com/art…
#Resuscitation
M. Bayer retweeted
📣 ➡️ “The prognosis in AMI-CS was not affected by admission time with a similar effect of ECLS during on- and off-hours.“ 😅 Good news for health care professionals 👨⚕️👩⚕️and patients. Thanks to @JACCJournals with nice editorial! Link: doi.org/10.1016/j.jcin.2024.…
M. Bayer retweeted
Timing of veno‐arterial extracorporeal membrane oxygenation support in patients with cardiogenic shock - @JonaSundermeyer @thiele_holger- European Journal of Heart Failure - @ESC_Journals onlinelibrary.wiley.com/doi/…







































